Immuneering Corp (IMRX) stock
IMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.46−0.06 (-1.70%)
Close on Nov 17, 2026Market cap $224.08MP/E –Yield –
Immuneering price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Immuneering's price to book ratio was 1.2× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.4× to 8.0×, with a median of 1.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.2× | +0.1 |
| 2025 | Dec 31, 2025 | 1.0× | −0.1 |
| 2024 | Dec 31, 2024 | 1.1× | −0.8 |
| 2023 | Dec 29, 2023 | 2.0× | +0.9 |
| 2022 | Dec 30, 2022 | 1.0× | +0.2 |
| 2021 | Dec 31, 2021 | 0.8× | – |
See a number that looks wrong?